Schizophrenia trials in Russia
1 trial · From ClinicalTrials.gov, checked 11 November 2026. Ask the study team whether a trial fits you.
- Phase 3Taking peopleEfficacy and Safety of Cariprazine in the Treatment of Adolescent Participants (13 to 17 Years of Age) With Schizophrenia
- Where
- Arkhangelsk, Kazan', Krasnodar, Lipetsk, Moscow, Nizhny Novgorod, Roshchino, Saint Petersburg, Samara, Saratov, Smolensk, Stavropol, Tomsk, Tonnel'nyy, Yaroslavl Region
- Age
- 13 years to 17 years
- People
- 330 worldwide
- Run by
- Gedeon Richter Plc.
See details and how to joinNCT03817502 · EU 2024-513194-44-00